E-medical diagnosis support system for non-invasive liver fibrosis recognition

Modern medical diagnosis systems very often accumulate numerous data. These computer medical support systems are used in monitoring and diagnosis, which require the various tools to interpret captured parameters. In the paper the new type of the computer medical support system has been presented. The system uses diagnostic conclusion method based on a similarity between the patient’s condition and diseases’ patterns contained in repository. On the basis of the repository data the classifier gives the most adequate decision. The new repository data are continuously stored. For this reason classifier can work in the self-tuning mode, what improves the classification quality.

[1]  Piotr Porwik,et al.  Adaptive Splitting and Selection Method for Noninvasive Recognition of Liver Fibrosis Stage , 2013, ACIIDS.

[2]  R. Soloway,et al.  APRI: An Easy and Validated Predictor of Hepatic Fibrosis in Chronic Hepatitis C , 2006, Journal of Clinical Gastroenterology.

[3]  Piotr Porwik,et al.  CLASSIFICATION TECHNIQUES FOR NON-INVASIVE RECOGNITION OF LIVER FIBROSIS STAGE , 2012 .

[4]  I. Guha,et al.  Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities. , 2008, Clinics in liver disease.

[5]  S. Friedman,et al.  Molecular regulation of hepatic fibrogenesis. , 1998, Journal of hepatology.

[6]  G. Ramadori,et al.  Fibrosis and Altered Matrix Synthesis , 1998, Digestion.

[7]  Bogdan Wojtyniak,et al.  Sytuacja zdrowotna ludności Polski i jej uwarunkowania , 2013 .

[8]  Dominique Thabut,et al.  Liver fibrosis evaluation using real-time shear wave elastography: applicability and diagnostic performance using methods without a gold standard. , 2013, Journal of hepatology.

[9]  D. Schuppan,et al.  Matrix as a modulator of hepatic fibrogenesis. , 2001, Seminars in liver disease.

[10]  Mion,et al.  [13C]‐Galactose breath test: correlation with liver fibrosis in chronic hepatitis C , 1999, European journal of clinical investigation.

[11]  R Luo,et al.  [Diagnostic value of five serum markers for liver fibrosis]. , 2001, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[12]  H Nishitani,et al.  Chronic liver disease: value of volumetry of liver and spleen with computed tomography. , 1990, Radiation medicine.

[13]  Neil Kaplowitz,et al.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.

[14]  K. Ishak,et al.  Histological grading and staging of chronic hepatitis. , 1995 .

[15]  E. Schiff,et al.  Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection , 2002, American Journal of Gastroenterology.

[16]  Chia-Yen Dai,et al.  The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies , 2007, Gut.

[17]  J. Marín-Gabriel,et al.  Noninvasive assessment of liver fibrosis. Serum markers and transient elastography (FibroScan). , 2009, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[18]  Mircea Grigorescu,et al.  Noninvasive biochemical markers of liver fibrosis. , 2006, Journal of gastrointestinal and liver diseases : JGLD.

[19]  Lin Dai,et al.  [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B]. , 2003, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[20]  Bartosz Krawczyk,et al.  Neural Network Ensemble Based on Feature Selection for Non-Invasive Recognition of Liver Fibrosis Stage , 2014 .

[21]  Herrine,et al.  Schiff's diseases of the liver , 1999, Gastroenterology.

[22]  M. Fried,et al.  13C‐methacetin breath test as a quantitative liver function test in patients with chronic hepatitis C infection: continuous automatic molecular correlation spectroscopy compared to isotopic ratio mass spectrometry , 2007, Alimentary pharmacology & therapeutics.

[23]  Piotr Porwik,et al.  Cost Sensitive Hierarchical Classifiers for Non-invasive Recognition of Liver Fibrosis Stage , 2013, CORES.